# MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression

> **NCT00187941** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Florida** · enrollment: 22 (actual)

## Conditions studied

- Transplantation, Renal
- Immunosuppression

## Interventions

- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT00187941
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187941, "MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00187941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*